Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

NCT03937154 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Thrombocytopenia

Interventions

DRUG: Romiplostim
DRUG: Placebo

Sponsor

Amgen